title: Does valvuloarterial impedance impact prognosis after surgery for severe aortic stenosis in the elderly?
abstract: Valvuloarterial impedance (Zva) was introduced as a prognostic measure in patients with aortic stenosis (AS). However, it is unclear whether Zva has a prognostic impact on survival after surgical aortic valve replacement (AVR) in patients with severe AS with preserved ejection fraction (EF).
  
  
  
  We retrospectively reviewed 929 consecutive patients who had AVR. We investigated 170 elderly patients (age >65 years, mean 76 years) who had AVR secondary to severe AS (mean gradient ≥40 mm Hg; aortic valve area ≤1 cm(2); peak velocity ≥4 m/s). Patients with EF <50%, greater than moderate aortic regurgitation, prior heart surgery and concomitant mitral or tricuspid valve surgery were excluded. Zva was calculated and the patients were divided into two groups; low Zva, Zva <4.3 (n=82) and high Zva, Zva ≥4.3 (n=88). The end point was all-cause of death. Survival curves were calculated according to Kaplan-Meier method.
  
  
  
  Age, prevalence of hypertension, diabetes, chronic kidney disease (CKD), atrial fibrillation, symptoms, EF, E/e' and concomitant coronary artery bypass graft were not different between the groups. Survival was not different between the groups at 5 years (70% in low Zva and 81% in high Zva; p=0.21) and for the entire follow-up period (p=0.23). Only age was a significant factor in predicting survival by multivariate analyses in Cox proportional hazards model after adjusting for Zva, CKD, atrial fibrillation and hypertension.
  
  
  
  Our results suggest that preoperative Zva does not have a prognostic impact on postoperative survival in elderly patients with severe AS with preserved EF. Further investigation is needed to elucidate the controversial results.
authors.affiliation: Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: Minako
authors.initials: M
authors.lastname: Katayama
authors.affiliation: Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: Mohammad Q
authors.initials: MQ
authors.lastname: Najib
authors.affiliation: Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: Punnaiah C
authors.initials: PC
authors.lastname: Marella
authors.affiliation: Division of Health Sciences Research , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: M'hamed H
authors.initials: MH
authors.lastname: Temkit
authors.affiliation: Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: Marek
authors.initials: M
authors.lastname: Belohlavek
authors.affiliation: Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
authors.forename: Hari P
authors.initials: HP
authors.lastname: Chaliki